At current levels, we recommend prospective investors to opt for GSK as compared to GILD on the back of a strong and wide ...

A little over two decades ago, addressing Nigeria's HIV crisis topped U.S. President George W. Bush's priorities. Africa's most populous nation had 3.5 million HIV cases, and the disease threatened to ...

Analysis - A little over two decades ago, addressing Nigeria's HIV crisis topped U.S. President George W. Bush's priorities. Africa's most populous nation had 3.5 million HIV cases, and the disease ...

GENEVA, 19 May 2025— As funding cuts threaten to cause an additional 6 million new HIV infections and 4 million preventable AIDS-related deaths, UNAIDS is calling on governments and partners attending ...

Protesters descended on Capitol Hill as lawmakers weighed $880B in Medicaid cuts that could strip coverage from millions. 'You will kill me!' shouted Olga, an HIV-positive Ohioan.

There are several ways to address HIV in homeless populations, with the most promising being the low barrier care model, ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Gilead Sciences’ long-acting drug to block HIV has the potential to end the AIDS epidemic worldwide. But accessibility ...